A peptide that activates GIP and GLP-1 receptors involved in appetite and blood-sugar regulation. Specific prescription formulations have proven medical uses; their results and approvals do not establish the quality or suitability of this catalog vial.
An investigational peptide acting on GLP-1, GIP, and glucagon receptors involved in appetite and metabolism. Clinical trials study weight and blood-sugar effects; it is not an FDA-approved medicine.
A mitochondrial-derived peptide studied for how cells respond to metabolic stress. Laboratory findings do not establish that this catalog product improves human energy, exercise performance, or longevity.
A copper-binding peptide studied for cell signaling and collagen production in laboratory models. Findings from skin or cell research do not establish the benefits or safety of an injectable product.
A coenzyme that helps cells carry out energy-related chemical reactions. Research on its normal cellular role does not establish that NAD+ infusions or injections improve energy or reverse aging.
A naturally occurring three-amino-acid molecule that helps cells manage oxidative stress. Its role as an antioxidant does not by itself establish benefits from taking this catalog product.
Each product or blend appears once, with its available sizes listed together. Select “More information” for a brief explanation and research sources. Listed sizes are per vial; contact MBB to confirm availability, packaging, and retail pricing.
5-Amino-1MQ
More information about 5-Amino-1MQ
A small molecule that blocks the NNMT enzyme, which is involved in cellular metabolism. It has been studied in obese mice; those findings do not establish weight-loss benefits in people.
Water containing acetic acid, listed as a solvent rather than a peptide. Its concentration and specifications need confirmation; it has no peptide-specific benefit.
The supplier name alone does not establish the exact molecule in this product. Its chemical identity and supporting research need confirmation before a reliable explanation of its effects can be given.
A copper-binding peptide studied in isolated human hair follicles and hair-follicle cells. Laboratory findings have not established that this product regrows hair in people.
Vitamin B12 helps the body make red blood cells and supports normal nerve function. Replacing a deficiency can help, but extra B12 has not been shown to boost energy in people who already have enough.
Short for bacteriostatic water: a water-based diluent with a preservative. It is not a peptide or a treatment on its own; this listing's formulation and quality specifications require confirmation.
A listed combination of BPC-157 and a TB-labelled peptide, associated with tissue-repair research. Studies of separate ingredients do not establish the blend's effects; the exact TB peptide should be confirmed.
An experimental peptide studied in laboratory and animal models of tissue repair, including tendons. These findings have not established a healing benefit or safety for general human use.
An investigational analogue of amylin, a hormone involved in fullness and appetite. It is being studied for weight management and is not an FDA-approved medicine.
Combines peptides associated with growth-hormone release through different signaling pathways. Findings for either ingredient alone do not establish the benefits or safety of this combination.
A growth-hormone-releasing hormone analogue with an attachment designed to prolong its action. Small human studies measured increases in growth hormone and IGF-1, without establishing anti-aging or muscle-building benefits.
Listed as a growth-hormone-releasing peptide without the long-acting DAC attachment. Confirm the exact sequence: research on long-acting CJC-1295 does not automatically apply to products sold under this name.
Delta sleep-inducing peptide is an experimental peptide investigated for sleep regulation. Small human studies have produced mixed findings; it is not an established insomnia treatment.
Also called epitalon, this short peptide has been studied for effects on telomeres, the protective ends of chromosomes, in cultured cells. That does not demonstrate longer life or age reversal in people.
An experimental peptide designed to disrupt survival signals in senescent cells, which have stopped dividing. Research in cells and mice does not establish an anti-aging benefit in humans.
A copper-binding peptide studied for cell signaling and collagen production in laboratory models. Findings from skin or cell research do not establish the benefits or safety of an injectable product.
A supplier blend name rather than a single peptide. The ingredient list and amounts are not specified in the supplied catalog, so its function cannot be reliably described until the formulation is confirmed.
A naturally occurring three-amino-acid molecule that helps cells manage oxidative stress. Its role as an antioxidant does not by itself establish benefits from taking this catalog product.
A modified form of insulin-like growth factor 1 used to study growth-related cell signaling. It interacts differently with binding proteins than natural IGF-1; that does not establish safe muscle-building use.
An experimental peptide that stimulates growth-hormone release. Research on hormone signaling does not establish it as a proven treatment for recovery, body composition, or healthy aging.
A peptide involved in signaling that controls reproductive hormones. Human studies have examined its effects on hormone release, but these do not establish general fertility or testosterone-boosting benefits.
A supplier blend name, not a standardized single peptide. The catalog gives a total amount but no ingredient breakdown; its research role and potential effects depend on the confirmed formulation.
A three-amino-acid peptide studied for effects on inflammatory signaling in cells and animal models of intestinal inflammation. A treatment benefit in people has not been established.
A nutrient involved in moving fatty acids into mitochondria, where cells can use them for energy. This normal biological role does not mean that an L-carnitine product reliably causes fat loss.
A branded product name rather than a single peptide. The exact formulation needs confirmation; the name alone does not establish fat-reduction benefits or suitability for injection.
A supplier name for a nutrient blend, rather than a single peptide. The catalog does not specify its ingredients or concentrations, so a specific metabolic or weight-loss effect cannot be inferred.
A name associated with afamelanotide, a peptide that affects skin-pigment signaling. A specific prescription implant is approved for a rare light-sensitivity disorder; that approval does not extend to this catalog vial.
An experimental peptide associated with skin-pigmentation research. It is not an established safe tanning treatment, and FDA has identified serious safety concerns.
Listed as a nutrient blend containing B12. The full formula and ingredient amounts need confirmation; the presence of B12 alone does not establish an energy or weight-loss benefit.
A mitochondrial-derived peptide studied for how cells respond to metabolic stress. Laboratory findings do not establish that this catalog product improves human energy, exercise performance, or longevity.
A coenzyme that helps cells carry out energy-related chemical reactions. Research on its normal cellular role does not establish that NAD+ infusions or injections improve energy or reverse aging.
Also called bremelanotide, a peptide that acts on melanocortin receptors. A specific prescription formulation treats certain low-desire disorders in premenopausal women; this catalog vial is not identified as that approved medicine.
An investigational peptide acting on GLP-1, GIP, and glucagon receptors involved in appetite and metabolism. Clinical trials study weight and blood-sugar effects; it is not an FDA-approved medicine.
More information about Retatrutide + Tirzepatide blend
Combines two substances with overlapping metabolic receptor targets. Evidence for each ingredient alone does not establish benefits or safety for this blend, and the catalog does not specify the amount of each ingredient.
An experimental peptide studied for effects on neurotransmitter signaling, including pathways involving GABA. These studies do not establish a reliable anxiety-relief benefit for this catalog product.
A GLP-1 receptor agonist that affects appetite and blood-sugar regulation. Specific prescription formulations have proven medical uses; those results and approvals do not establish the quality or suitability of this catalog vial.
An experimental peptide studied for brain-cell signaling and responses to injury, including in rat models. Those findings do not establish improved memory, focus, or stroke recovery from this catalog product.
Combines two peptides studied separately for nervous-system signaling. Research on the individual ingredients does not establish that the combination improves focus, mood, or anxiety.
An analogue of growth-hormone-releasing hormone that signals the pituitary gland to release growth hormone. That hormonal action does not establish general anti-aging, fat-loss, or muscle-building benefits.
A supplier-listed cosmetic peptide name associated with topical skin-care ingredients. Confirm the exact ingredient and formulation; information about a topical cosmetic does not establish benefits from an injectable vial.
Also called elamipretide, a peptide that binds cardiolipin in mitochondria. Its prescription formulation, Forzinity, has a specific approval for Barth syndrome; this does not establish general anti-aging benefits or approval of this vial.
A name used for products associated with thymosin beta-4 research on cell movement and tissue repair. The exact peptide or fragment must be confirmed; findings about the full protein cannot automatically be applied to every TB500 product.
A growth-hormone-releasing hormone analogue. Its prescription formulation reduces excess abdominal fat in adults with HIV-associated lipodystrophy; it is not a general weight-loss medicine, and that approval does not extend to this catalog vial.
More information about Tesamorelin + Ipamorelin blend
Combines two peptides that influence growth-hormone release. Tesamorelin's prescription approval and research on ipamorelin do not establish benefits or safety for this combination.
These names refer to different thymus-related substances, not interchangeable names for one peptide. The catalog does not identify which is supplied; confirm the exact substance before applying research about immune signaling.
A peptide studied for effects on immune responses in specific illnesses. Clinical findings vary; this research does not establish a general immune-boosting benefit for healthy people.
A peptide that activates GIP and GLP-1 receptors involved in appetite and blood-sugar regulation. Specific prescription formulations have proven medical uses; their results and approvals do not establish the quality or suitability of this catalog vial.
Vasoactive intestinal peptide is a naturally occurring signaling molecule studied for effects including widening blood vessels. These physiological effects do not establish a general wellness benefit from a VIP product.
These are supplier codes with no identified substance in the provided lists. Both codes list 10 mL; the name, composition, and purpose must be confirmed before a meaningful description is possible.
10 mL
WA3 and WA10 both list 10 mL. Product identity and specifications need confirmation.